Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme

Jamil,S.; Cedervall,J.; Hultman,I.; Ali,R.; Margaryan,N.  V.; Rasmuson,A.; Johnsen,J.  I.; Sveinbjörnsson,B.; Dalianis,T.; Kanter,L.; Orrego,A.; Strizzi,L.; Hendrix,M.  J.C.; Sandstedt,B.; Kogner,P.; Ährlund-Richter,L.

doi:10.3892/ijo.2013.2014

Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme

Authors:
- S. Jamil
- J. Cedervall
- I. Hultman
- R. Ali
- N. V. Margaryan
- A. Rasmuson
- J. I. Johnsen
- B. Sveinbjörnsson
- T. Dalianis
- L. Kanter
- A. Orrego
- L. Strizzi
- M. J.C. Hendrix
- B. Sandstedt
- P. Kogner
- L. Ährlund-Richter
View Affiliations

Affiliations: Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden, Department of Neuroscience, Karolinska Institute, Stockholm, Sweden, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA, Division of Molecular Inflammation Research, University of Tromsö, Tromsö, Norway, Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden
Published online on: July 12, 2013 https://doi.org/10.3892/ijo.2013.2014
Pages: 831-838

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Embryonic neural tumors are responsible for a disproportionate number of cancer deaths in children. Although dramatic improvements in survival for pediatric malignancy has been achieved in previous years advancements seem to be slowing down. For the development of new enhanced therapy and an increased understanding of the disease, pre-clinical models better capturing the neoplastic niche are essential. Tumors of early childhood present in this respect a particular challenge. Here, we explore how components of the embryonic process in stem‑cell induced mature teratoma can function as an experimental in vivo microenvironment instigating the growth of injected childhood neuroblastoma (NB) cell lines. Three human NB cell lines, IMR-32, Kelly and SK-N-BE(2), were injected into mature pluripotent stem cell‑induced teratoma (PSCT) and compared to xenografts of the same cell lines. Proliferative NB cells from all lines were readily detected in both models with a typical histology of a poorly differentiated NB tumor with a variable amount of fibrovascular stroma. Uniquely in the PSCT microenvironment, NB cells were found integrated in a non‑random fashion. Neuroblastoma cells were never observed in areas with well-differentiated somatic tissue i.e. bone, muscle, gut or areas of other easily identifiable tissue types. Instead, the three cell lines all showed initial growth exclusively occurring in the embryonic loose mesenchymal stroma, resulting in a histology recapitulating NB native presentation in vivo. Whether this reflects the ‘open’ nature of loose mesenchyme more easily giving space to new cells compared to other more dense tissues, the rigidity of matrix providing physical cues modulating NB characteristics, or if embryonic loose mesenchyme may supply developmental cues that attracted or promoted the integration of NB, remains to be tested. We tentatively hypothesize that mature PSCT provide an embryonic niche well suited for in vivo studies on NB.

View Figures

View References

1	Brodeur GM and Maris JM: Neuroblastoma. Principles and Practice of Pediatric Oncology. Pizzo PA and Poplack DG: 5th edition. J.B. Lippincott & Co; Philadelphia, PA: pp. 933–970. 2006
2	Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
3	Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003. View Article : Google Scholar : PubMed/NCBI
4	Johnsen JI, Kogner P, Albihn A and Henriksson MA: Embryonal neural tumours and cell death. Apoptosis. 14:424–438. 2009. View Article : Google Scholar : PubMed/NCBI
5	Mohlin SA, Wigerup C and Påhlman S: Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage. Semin Cancer Biol. 21:276–282. 2011. View Article : Google Scholar : PubMed/NCBI
6	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
7	Blum B and Benvenisty N: The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 100:133–158. 2008. View Article : Google Scholar
8	Cedervall J, Gertow K, Damjanov I and Ährlund-Richter L: Characterization of human pluripotent stem cell-derived teratoma. Human Stem Cell Manual. Loring JF and Peterson S: 2nd edition. Elsevier Press; Philadelphia, PA: pp. 345–360. 2012, View Article : Google Scholar
9	Gertow K, Wolbank S, Rozell B, Sugars R, Andäng M, Parish CL, Imreh MP, Wendel M and Ährlund-Richter L: Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev. 13:421–435. 2004. View Article : Google Scholar : PubMed/NCBI
10	Gertow K, Cedervall J, Jamil S, Ali R, Imreh MP, Parish CL, Imreh MP, Wendel M and Ährlund-Richter L: Early events in xenograft development from the human embryonic stem cell line HS181 - resemblance with an initial multiple epiblast formation. PLoS One. 6:e277412011. View Article : Google Scholar : PubMed/NCBI
11	Lensch MW and Ince TA: The terminology of teratocarcinomas and teratomas. Nat Biotechnol. 25:12112007. View Article : Google Scholar : PubMed/NCBI
12	Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R and Skorecki K: An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci USA. 100:13507–13512. 2003. View Article : Google Scholar : PubMed/NCBI
13	Tzukerman M, Rosenberg T, Reiter I, Ben-Eliezer S, Denkberg G, Coleman R, Reiter Y and Skorecki K: The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res. 66:3792–3801. 2006. View Article : Google Scholar : PubMed/NCBI
14	Katz E, Skorecki K and Tzukerman M: Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin Cancer Res. 15:70–80. 2006. View Article : Google Scholar : PubMed/NCBI
15	Cedervall J, Jamil S, Prasmickaite L, Cheng Y, Eskandarpour M, Hansson J, Maelandsmo GM, Ringborg U, Gulyas M, Suo Z, Kanter L and Ährlund-Richter L: Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts. Cancer Res. 69:3746–3754. 2009. View Article : Google Scholar : PubMed/NCBI
16	Hovatta O, Mikkola M, Gertow K, Strömberg AM, Inzunza J, Hreinsson J, Rozell B, Blennow E, Andäng M and Ährlund-Richter L: A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod. 18:1404–1409. 2003. View Article : Google Scholar : PubMed/NCBI
17	Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 282:1145–1147. 1998. View Article : Google Scholar : PubMed/NCBI
18	Imreh MP, Wolbank S, Unger C, Gertow K, Aints A, Szeles A, Imreh S, Hovatta O, Fried G, Dilber S and Ährlund-Richter L: Culture and expansion of the human embryonic stem cell line HS181, evaluated in a double-color system. Stem Cells Dev. 13:337–343. 2004. View Article : Google Scholar : PubMed/NCBI
19	Joshi VV, Cantor AB, Altshuler G, Larkin EW, Neill JS, Shuster JJ, Holbrook CT, Hayes FA and Castleberry RP: Recommendations for modification of terminology of neuroblastic tumor and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer. 69:2183–2196. 1992. View Article : Google Scholar : PubMed/NCBI
20	Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN and Matthay KK: International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children’s Cancer Group. Cancer. 92:2451–2461. 2001.
21	Lam WA, Cao L, Umesh V, Keung AJ, Sen S and Kumar S: Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression. Mol Cancer. 9:1–7. 2010.PubMed/NCBI
22	Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A and Gilbertson RJ: A perivascular niche for brain tumor stem cells. Cancer Cell. 11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
23	Schier AF: Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol. 19:589–621. 2003. View Article : Google Scholar : PubMed/NCBI
24	Shen MM: Nodal signaling: developmental roles and regulation. Development. 134:1023–1034. 2007. View Article : Google Scholar : PubMed/NCBI
25	Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE and Hendrix MJ: Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA. 105:4329–4334. 2008. View Article : Google Scholar : PubMed/NCBI
26	Papageorgiou I, Nicholls PK, Wang F, Lackmann M, Makanji Y, Salamonsen LA, Robertson DM and Harrison CA: Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol. 7:1222009. View Article : Google Scholar : PubMed/NCBI
27	Lee CC, Jan HJ, Lai JH, Ma HI, Hueng DY, Lee YC, Cheng YY, Liu LW, Wei HW and Lee HM: Nodal promotes growth and invasion in human gliomas. Oncogene. 29:3110–3123. 2010. View Article : Google Scholar : PubMed/NCBI
28	Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR and Lai J; APC BioResource. Postovit LM, Clements JA and Hendrix MJ: Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate. 71:1198–1209. 2011.PubMed/NCBI